Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Retained Earnings (2020 - 2026)

Alvotech's (ALVO) quarterly Retained Earnings came in at -$2.5 billion in Q2 2026, down 7.82% on a YoY basis from -$2.7 billion in Q2 2025, and down 2.77% quarter-over-quarter from -$2.4 billion in Q1 2026.

Analysis

Alvotech (ALVO) Retained Earnings (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Retained Earnings for 7 consecutive years, with -$2.5 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Retained Earnings fell 7.82% year-over-year to -$2.5 billion; the trailing twelve-month figure through Jun 2026 stood at -$2.5 billion (down 7.82% YoY), and the FY2025 full-year result was -$2.4 billion, up 1.15% from the prior year.
  • Retained Earnings declined to -$2.5 billion in Q2 2026 per ALVO's latest filing, from -$2.4 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at -$1.3 billion in Q2 2022 and bottomed at -$2.5 billion in Q2 2026.
  • Historically, Retained Earnings has averaged -$2.2 billion across 5 years, with a median of -$2.4 billion in 2024.
  • The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 45.03% in 2022, then climbed 2.69% in 2025.
  • Over 5 years, Retained Earnings stood at -$1.7 billion in 2022, then sank by 33.36% to -$2.2 billion in 2023, then declined by 10.51% to -$2.4 billion in 2024, then increased by 1.15% to -$2.4 billion in 2025, then decreased by 2.73% to -$2.5 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$2.5 billion, -$2.4 billion, and -$2.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 28.26 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 18.56 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 3.76 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 545.58 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn -10.83 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 620.25 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -2.48 Bn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 703.65 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn -227.25 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 54.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.48 Bn
Mar 31, 2026 -2.41 Bn
Dec 31, 2025 -2.41 Bn
Sep 30, 2025 -2.44 Bn
Jun 30, 2025 -2.30 Bn
Mar 31, 2025 -2.44 Bn
Dec 31, 2024 -2.44 Bn
Sep 30, 2024 -2.37 Bn
Jun 30, 2024 -2.36 Bn
Mar 31, 2024 -2.42 Bn
Dec 31, 2023 -2.21 Bn
Jun 30, 2023 -1.74 Bn
Dec 31, 2022 -1.65 Bn
Jun 30, 2022 -1.33 Bn
Dec 31, 2021 -1.14 Bn
Dec 31, 2020 -1.04 Bn